David Fox, Partner, Hogan Lovells
David Fox is a leading authority on the regulation of prescription and over-the-counter drugs, biological products, combination products, and controlled
He advises management teams, from start-ups to the largest global pharmaceutical and biotechnology companies, on matters before the Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA).
David is closely integrated with funding sources for the industry and is frequently retained as a strategic advisor on assessing the value of life sciences assets.
Known for his collaborative approach to complex regulatory issues, David has successfully resolved numerous disputes between sponsors and staff at FDA on products that raise novel regulatory issues.